Peterson Caryn
SEC CIK 1857256 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| GOSS | Gossamer Bio, Inc. | EVP, Regulatory Affairs | 259.3K | — | $152.2K | 7 | 2021-10-25 | 2026-01-02 |
Most active insiders at GOSS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Smith Robert Paul JR | Chief Commercial Off | — | — |
| 2 | Aranda Richard | Chief Medical Off | — | — |
| 3 | Peterson Caryn | EVP, Regulatory Affairs | — | — |
| 4 | Giraudo Bryan | COO, CFO | — | — |
| 5 | Christian Waage | EVP, Tech Ops, Admin | — | — |
| 6 | Hasnain Faheem | Pres, CEO, Dir | — | — |
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-05 | 2026-01-02 | GOSS | Gossamer Bio, Inc. | Peterson Caryn | EVP, Regulatory Affairs | A - Grant | $0.00 | +84.5K | 259.3K | +48% | $0 |
| 2025-10-02 | 2025-10-01 | GOSS | Gossamer Bio, Inc. | Peterson Caryn | EVP, Regulatory Affairs | A - Grant | $0.00 | +125.0K | 174.8K | +251% | $0 | |
| 2024-03-19 | 2024-03-18 | GOSS | Gossamer Bio, Inc. | Peterson Caryn | EVP, Regulatory Affairs | S - Sale | $1.33 | -4,018 | 49.8K | -7% | -$5,344 | |
| 2023-03-20 | 2023-03-16 | GOSS | Gossamer Bio, Inc. | Peterson Caryn | EVP, Regulatory Affairs | S - Sale | $1.10 | -7,564 | 53.9K | -12% | -$8,320 | |
| 2022-10-25 | 2022-10-24 | GOSS | Gossamer Bio, Inc. | Peterson Caryn | EVP, Regulatory Affairs | S - Sale | $12.07 | -4,757 | 61.4K | -7% | -$57.4K | |
| 2022-03-17 | 2022-03-16 | GOSS | Gossamer Bio, Inc. | Peterson Caryn | EVP, Regulatory Affairs | S - Sale | $8.28 | -6,279 | 66.2K | -9% | -$52.0K | |
| 2021-10-26 | 2021-10-25 | GOSS | Gossamer Bio, Inc. | Peterson Caryn | EVP, Regulatory Affairs | S - Sale | $12.25 | -2,377 | 72.5K | -3% | -$29.1K |
Purchase Sale Sale after option exercise All abbreviations